Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 545-551

  Omrane, Ines ^a   Baroudi, Olfa ^a   Kourda, Nadia ^b   Bignon, Yves Jean ^c   Uhrhammer, Nancy ^c   Desrichard, Alexis ^c   Medimegh, Imen ^a   Ayari, Hager ^a   Stambouli, Nejla ^a   Mezlini, Amel ^d   Bouzayenne, Hssan ^a   Marrakchi, Raja ^a   Benammar Elgaaid, Amel ^a   Bougatef, Karim ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b CHARLES NICOLLE HOSPITAL   (Tunisia)

^c CENTRE JEAN PERRIN   (France)

^d SALAH AZAIEZ INSTITUTE   (Tunisia)

Author keywords

Clinicopathological characteristics; Colorectal cancer; Lymph nodemetastasis; Polymorphisms; TLR4; Tunisian population

Indexed keywords

BIOLOGICAL MARKER; GENOMIC DNA; TOLL LIKE RECEPTOR 4;

ADULT; ADVANCED CANCER; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 4 GENE; TUMOR DIFFERENTIATION; TUNISIA;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4; TUNISIA;

EID: 84894425546     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1075-6     Document Type: Article

References (40)

1. Vasselon T, Detmers PA. Toll receptors: a central element in innate immune responses. Infect Immun. 2002;70(3):1033-41.
2. Ferwerda B,McCallMB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med (Cambridge, Mass). 2008;14(5-6):346-52.
3. Yang IA, Barton SJ, Rorke S, Cakebread JA, Keith TP, Clough JB, et al. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun. 2004;5(1):41-5.
4. Montes AH, Asensi V, Alvarez V, Valle E, Ocana MG, Meana A, et al. The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor forGram-negative and haematogenous osteomyelitis. Clin Exp Immunol. 2006;143(3):404-13.
5. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347(3):185-92.
6. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology. 2007;132(3):905-12.
7. Shen X, Shi R, Zhang H, Li K, Zhao Y, Zhang R. The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn's disease and ulcerative colitis: a meta-analysis. Digestion. 2010;81(2):69-77.
8. Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004;5(5):417-25.
9. Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis. 2005;11(7):645-52.
10. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut. 2004;53(7):987-92.
11. Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis. 2005;11(6):567-75.
12. Agundez JA, Garcia-Martin E, Devesa MJ, Carballo M, Martinez C, Lee-Brunner A, et al. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma. Oncology. 2012;82(1):35-40.
13. Belforte S, Coluccio Leskow F, Poskus E, Penas SA. Toll-like receptor 4 D299G polymorphism in metabolic disorders: a metaanalysis. Mol Biol Rep. 2013;40:3015-20.
14. Mantovani A. Cancer: inflammation by remote control. Nature. 2005;435(7043):752-3.
15. Sun J, Wiklund F, Hsu FC, Balter K, Zheng SL, Johansson JE, et al. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epidemiol Biomark Prev. 2006;15(3):480-5.
16. Gast A, Bermejo JL, Claus R, Brandt A, Weires M, Weber A, et al. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival. PloS One. 2011;6(9):e24370.
17. Pimentel-Nunes P, Teixeira AL, Pereira C, Gomes M, Brandao C, Rodrigues C, et al. Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis. 2013;45(1):63-9.
18. Shen Y, Liu Y, Liu S, Zhang A. Toll-like receptor 4 gene polymorphisms and susceptibility to bladder cancer. Pathol Oncol Res. 2013;19:275-80.
19. Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, et al. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast. 2012;21(4):534-8.
20. Zheng SL, Augustsson-Balter K, Chang B, Hedelin M, Li L, Adami HO, et al. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 2004;64(8):2918-22.
21. Bhattacharya D, Yusuf N. Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. International journal of breast cancer. 2012; 2012:716564
22. Furrie E,Macfarlane S, Thomson G,Macfarlane GT. Toll-like receptors- 2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology. 2005;115(4):565-74.
23. Cammarota R, Bertolini V, Pennesi G, Bucci EO, Gottardi O, Garlanda C, et al. The tumormicroenvironment of colorectal cancer: stromal TLR-4 expression as a potential prognostic marker. J Trans Med. 2010;8:112.
24. Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R, Kirkpatrick CJ. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med. 2007;20(1):21-9.
25. Deschoolmeester V, Baay M, Lardon F, Pauwels P, Peeters M. Immune cells in colorectal cancer: prognostic relevance and role of MSI. Cancer Microenviron. 2011;4(3):377-92.
26. MustaphaMA, Shahpudin SN, Aziz AA, Ankathil R. Risk modification of colorectal cancer susceptibility by interleukin-8-251T>A polymorphism in Malaysians. World J Gastroenterol. 2012;18(21):2668-73.
27. Ferwerda B, McCall MB, Alonso S, Giamarellos-Bourboulis EJ, Mouktaroudi M, Izagirre N, et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A. 2007;104(42):16645-50.
28. Kopp E, Medzhitov R. Recognition of microbial infection by Tolllike receptors. Curr Opin Immunol. 2003;15(4):396-401.
29. Oblak A, Jerala R. Toll-like receptor 4 activation in cancer progression and therapy. Clinical & developmental immunology. 2011; 2011:609579
30. El-OmarEM, NgMT, Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene. 2008;27(2):244-52.
31. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25(2):187-91.
32. SlatteryML, Herrick JS, Bondurant KL,Wolff RK. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer. 2012;130(12):2974-80.
33. Davoodi H, Seow HF. Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol. 2011;10(2):91-9.
34. Guo Q, Zhu J, Xia B. Polymorphism of CD14 gene but not the mutation of TLR4 gene is associated with colorectal cancer in Chinese patients. J Gastroenterol Hepatol. 2006;21(1 Pt 1):92-7.
35. Eyking A, Ey B, Runzi M, Roig AI, Reis H, Schmid KW, et al. Tolllike receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology. 2011;141(6):2154-65.
36. Wang EL, Qian ZR, NakasonoM, Tanahashi T, Yoshimoto K, Bando Y, et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer. 2010;102(5):908-15.
37. Jia HP, Kline JN, Penisten A, Apicella MA, Gioannini TL, Weiss J, et al. Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. Am J Physiol. 2004;287(2):L428-37.
38. Prohinar P, Rallabhandi P, Weiss JP, Gioannini TL. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4. J Immunol. 2010;184(8):4362-7.
39. FukataM, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, et al. Toll-like receptor-4 promotes the development of colitisassociated colorectal tumors. Gastroenterology. 2007;133(6):1869-81.
40. Hsu RY, Chan CH, Spicer JD, Rousseau MC, Giannias B, Rousseau S, et al. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis. Cancer Res. 2011;71(5):1989-98.